The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Doxepin
Doxepin · DOXEPIN HYDROCHLORIDE 6 mg/1 · Tablet · Oral · NorthStar Rx LLC
NDC 72603-0920-01 · 30 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for doxepin (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA216041
- TE code
- AB
- Approval date
- Jul 25, 2024
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Doxepin (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Ajanta Pharma USA Inc. | DOXEPIN HYDROCHLORIDE 3 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ajanta Pharma USA Inc. | DOXEPIN HYDROCHLORIDE 6 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | DOXEPIN HYDROCHLORIDE 3 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | DOXEPIN HYDROCHLORIDE 6 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar Rx LLC | DOXEPIN HYDROCHLORIDE 3 mg/1 | Aug 5, 2026 | Sep 2, 2026 |
| NorthStar Rx LLC | DOXEPIN HYDROCHLORIDE 6 mg/1 | Aug 5, 2026 | Sep 2, 2026 |
| Viona Pharmaceuticals Inc | DOXEPIN HYDROCHLORIDE 6 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Viona Pharmaceuticals Inc | DOXEPIN HYDROCHLORIDE 3 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | DOXEPIN HYDROCHLORIDE 3 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | DOXEPIN HYDROCHLORIDE 6 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Doxepin — NDC 72603-0920-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72603092001.
Free to cite with attribution — see how the data is put together.